Australia is experience innovative therapy for excess weight: Retatrutide. This new dual compound – working on both GLP-1 and GIP receptors – has promising efficacy in international trials, pointing to considerable reductions in weight. While availability is pending with Australian regulators, many Australians battling obesity are hoping for Re… Read More